To kick off discussions, John Li, Vice Chair to the IPR Working Group in Shanghai, and Head of Patents at Novartis China, will be holding a presentation on the role of IPR in China’s pharmaceutical sector in China as well as recent policy developments.
Agenda:
· 15:30 – 16:00 Registration
· 16:00 – 16.10: Welcome words
· 16:10 – 16:40: Presentation on the role of IPR in the pharmaceutical sector in China policy developments as well as drug exclusivity in CFDA reform. by John Li, Vice Chair to the IPR WG and in Shanghai
· 16:40 – 16:50: Q&A
· 16:50 – 17:30 Roundtable discussion with focus on lobby position of EUCCC IP and Pharma WGs
